PharmaCyte Biotech, Inc. discloses 50% stake in Q/C Technologies
Technologies
- 50%[1]
PharmaCyte Biotech, Inc. reported a 50% stake in Q/C Technologies (QCLS) in a Schedule 13D filed with the SEC on Nov 21, 2026. The filing covers 8,446,093 shares.[1]
| Reporting person | Security | Shares | Ownership | Filed |
|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | Q/C Technologies, Inc | 8,446,093 | 50% | 2026-11-21 |
Keep reading
Built by fixed rules from the filing as filed, with no AI writing. A filing does not show why anyone traded. Report a correction.